Walgreens Boots Alliance
WBA
Market cap $9.97B

11.52 USD

+0.01

0.09%

At close Jul 16, 4:00 PM EDT

After hours

11.50

-0.02

0.17%

1 day

0.09%

5 days

-0.43%

1 month

1.05%

3 months

6.67%

6 months

-10.90%

Year to date

25.35%

1 year

-1.79%

5 years

-72.14%

10 years

-88.01%

About: Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Employees: 312,000

Healthcare Pharmaceutical Retailers

0

Funds holding %

of 7,317 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

60% more funds holding in top 10

Funds holding in top 10: 5 [Q4 2024] → 8 (+3) [Q1 2025]

26% more call options, than puts

Call options by funds: $357M | Put options by funds: $284M

16% more capital invested

Capital invested by funds: $4.99B [Q4 2024] → $5.77B (+$779M) [Q1 2025]

10% less first-time investments, than exits

New positions opened: 140 | Existing positions closed: 155

2.25% less ownership

Funds ownership: 61.87% [Q4 2024] → 59.62% (-2.25%) [Q1 2025]

4% less funds holding

Funds holding: 867 [Q4 2024] → 833 (-34) [Q1 2025]

26% less repeat investments, than reductions

Existing positions increased: 228 | Existing positions reduced: 310

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for WBA.

See Analyst Rankings

Financial journalist opinion

Based on 27 articles about WBA published over the past 30 days

Premier Medical Collaborates with Walgreens to Expand Access to Care Across Central Florida

ORLANDO, Fla.--(BUSINESS WIRE)--Premier Medical, a leading primary and multispecialty care provider in Central Florida, today announces a new collaboration with Walgreens to increase access to high-quality healthcare in local communities. Beginning this summer, Premier Medical, which is a part of the value-driven healthcare company, NeueHealth, will begin operating clinics inside select Walgreens locations, starting with two sites opening in Davenport, Fla., and Orlando, Fla., in July 2025. The.

Premier Medical Collaborates with Walgreens to Expand Access to Care Across Central Florida

Walgreens Takes Major Step Toward Becoming Private Company Again

Walgreens Boots Alliance Inc. has taken a major step forward in its bid to go private after it announced that at the Company's Special Meeting of Shareholders, WBA shareholders had approved the previously announced acquisition of the company by entities affiliated with Sycamore Partners Management.

Walgreens Takes Major Step Toward Becoming Private Company Again

Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys

High-yield S&P 500 stocks can be risky, but 14 "safer" S&P 500 dividend dogs have strong free cash flow to support payouts and are attractive buys. Analyst forecasts suggest top ten S&P 500 dividend dogs could deliver 27% to 53% net gains by July 2026, with lower-than-market volatility. A market correction could make more high-yield stocks fairly priced; currently, only a select few meet the 'dogcatcher' ideal of yield from $1K invested exceeding share price.

Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys

Walgreens Shareholders Approve $10 Billion Private Equity Buyout

Walgreens Boots Alliance shareholders Friday approved private equity firm Sycamore Partners' $10 billion buyout offer for the iconic drugstore chain.

Walgreens Shareholders Approve $10 Billion Private Equity Buyout

Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “Company” or “WBA”) today announced that at the Company's Special Meeting of Shareholders (the “Special Meeting”), WBA shareholders approved the previously announced acquisition of the Company by entities affiliated with Sycamore Partners Management, L.P. (“Sycamore”). According to the preliminary results, approximately 96% of votes cast at the Special Meeting by all shareholders were voted in favor of the merge.

Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners

The Motley Fool

3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Normally, a buy-and-hold strategy pays off, and investors expect to see strong gains from their investments. The S&P 500 (^GSPC -0.79%) has risen by 200% over the past decade, and mirroring the index would have enabled you to triple your money.

3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Cash Flow Matters: Two Cheap Stocks With Relatively Secure Dividends And Upside Potential

Despite new S&P highs, I expect continued market volatility and see a 50/50 chance of recession in the next 6–12 months. The Fed's reluctance to cut rates, ongoing trade tensions, and potential stagflation keep me cautious, even as market sentiment turns greedy. Realty Income remains attractive for dividend investors due to its diversified portfolio, strong balance sheet, and proactive management despite tenant challenges.

Cash Flow Matters: Two Cheap Stocks With Relatively Secure Dividends And Upside Potential

The Motley Fool

3 Things You Need to Know If You Buy Walgreens Today

Walgreens Boots Alliance (WBA -0.13%) is one of the largest pharmacy retailers in the United States. Over the past several years, the company has made a number of poor investment decisions.

3 Things You Need to Know If You Buy Walgreens Today

Walgreens Outlook Improves As Buyout Faces Shareholder Vote Next Month

News that Walgreens Boots Alliance quarterly loss was better than expected and pharmacy sales are rising bodes well for a financial turnaround under new private equity ownership.

Walgreens Outlook Improves As Buyout Faces Shareholder Vote Next Month

Walgreens Sales Rise but CEO Says Turnaround Will ‘Take Time'

Walgreens is reportedly seeing an uptick in sales as it prepares to go private. [contact-form-7] The company released quarterly earnings Thursday (June 26) showing sales of $39 billion, a 7.2% increase from the same quarter last year, driven by growth in its American retail pharmacy and international segments.

Walgreens Sales Rise but CEO Says Turnaround Will ‘Take Time'

See News Rankings

Charts implemented using Lightweight Charts™